中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2012年
1期
65-69
,共5页
杨岩丽%李宝生%尹勇%陈进琥%孙涛%孙洪福
楊巖麗%李寶生%尹勇%陳進琥%孫濤%孫洪福
양암려%리보생%윤용%진진호%손도%손홍복
食管癌%剂量学参数%三维适形放疗%调强放射治疗%旋转调强
食管癌%劑量學參數%三維適形放療%調彊放射治療%鏇轉調彊
식관암%제량학삼수%삼유괄형방료%조강방사치료%선전조강
Thoracic esophageal cancer%Dosimetric parameter%Three-dimensional conformal radiotherapy%Intensity-modulated radiotherapy%Volumetric modulated arc radiotherapy
目的 比较胸段食管癌3种放疗技术( 3D-CRT、IMRT、RapidArc)的剂量学特点,并分析3种技术的优劣及应用特点.方法 15例胸段食管癌患者入组,依据CT图像,勾画靶区,针对患者的同一套CT图像的相同靶区分别制定3D-CRT、5野IMRT(IMRT5)、7野IMRT( IMRT7)、9野IMRT(IMRT9)、单弧Arc( Arc1)、双弧Arc( Arc2)共6套计划.PTV处方剂量为40 Gy分20次4周+19.6 Gy分14次7d.结果 3D-CRT计划各项靶区剂量学参数明显差于IMRT计划及RapidArc计划(t=5.77、3.52,P<0.05),6套计划的PTV V95(%)分别为:3D-CRT (91.55 ±2.90),IMRT5(96.66±1.05),IMRT7 (96.87±1.23),IMRT (96.81±1.16),Arcl (94.98±1.41),Arc2 (95.93±1.32).RapidArc计划的靶区适形度(CI)最好(t=3.76,10.01,P<0.05),IMRT计划的靶区均匀性(HI)最好(t =3.93、3.37,P<0.05).危及器官参数RapidArc与IMRT各计划之间差异无统计学意义.3D-CRT和RapidArc计划的机器跳数明显少于IMRT计划,差异高达75%.结论 对于胸段食管癌患者,采用IMRT或RapidArc技术可以在保护正常组织的同时,涵盖临床必需的治疗靶区.3D-CRT计划对降低正常组织低剂量散射区方面优势明显.RapidArc计划靶区剂量学参数与IMRT计划比较未见明显优势.
目的 比較胸段食管癌3種放療技術( 3D-CRT、IMRT、RapidArc)的劑量學特點,併分析3種技術的優劣及應用特點.方法 15例胸段食管癌患者入組,依據CT圖像,勾畫靶區,針對患者的同一套CT圖像的相同靶區分彆製定3D-CRT、5野IMRT(IMRT5)、7野IMRT( IMRT7)、9野IMRT(IMRT9)、單弧Arc( Arc1)、雙弧Arc( Arc2)共6套計劃.PTV處方劑量為40 Gy分20次4週+19.6 Gy分14次7d.結果 3D-CRT計劃各項靶區劑量學參數明顯差于IMRT計劃及RapidArc計劃(t=5.77、3.52,P<0.05),6套計劃的PTV V95(%)分彆為:3D-CRT (91.55 ±2.90),IMRT5(96.66±1.05),IMRT7 (96.87±1.23),IMRT (96.81±1.16),Arcl (94.98±1.41),Arc2 (95.93±1.32).RapidArc計劃的靶區適形度(CI)最好(t=3.76,10.01,P<0.05),IMRT計劃的靶區均勻性(HI)最好(t =3.93、3.37,P<0.05).危及器官參數RapidArc與IMRT各計劃之間差異無統計學意義.3D-CRT和RapidArc計劃的機器跳數明顯少于IMRT計劃,差異高達75%.結論 對于胸段食管癌患者,採用IMRT或RapidArc技術可以在保護正常組織的同時,涵蓋臨床必需的治療靶區.3D-CRT計劃對降低正常組織低劑量散射區方麵優勢明顯.RapidArc計劃靶區劑量學參數與IMRT計劃比較未見明顯優勢.
목적 비교흉단식관암3충방료기술( 3D-CRT、IMRT、RapidArc)적제량학특점,병분석3충기술적우렬급응용특점.방법 15례흉단식관암환자입조,의거CT도상,구화파구,침대환자적동일투CT도상적상동파구분별제정3D-CRT、5야IMRT(IMRT5)、7야IMRT( IMRT7)、9야IMRT(IMRT9)、단호Arc( Arc1)、쌍호Arc( Arc2)공6투계화.PTV처방제량위40 Gy분20차4주+19.6 Gy분14차7d.결과 3D-CRT계화각항파구제량학삼수명현차우IMRT계화급RapidArc계화(t=5.77、3.52,P<0.05),6투계화적PTV V95(%)분별위:3D-CRT (91.55 ±2.90),IMRT5(96.66±1.05),IMRT7 (96.87±1.23),IMRT (96.81±1.16),Arcl (94.98±1.41),Arc2 (95.93±1.32).RapidArc계화적파구괄형도(CI)최호(t=3.76,10.01,P<0.05),IMRT계화적파구균균성(HI)최호(t =3.93、3.37,P<0.05).위급기관삼수RapidArc여IMRT각계화지간차이무통계학의의.3D-CRT화RapidArc계화적궤기도수명현소우IMRT계화,차이고체75%.결론 대우흉단식관암환자,채용IMRT혹RapidArc기술가이재보호정상조직적동시,함개림상필수적치료파구.3D-CRT계화대강저정상조직저제량산사구방면우세명현.RapidArc계화파구제량학삼수여IMRT계화비교미견명현우세.
Objective To compare the dosimetric characteristics of intensity-modulated arc therapy( IMAT ),fixed-gantry intensity-modulated radiotherapy ( IMRT ) and 3-dimensional conformal radiotherapy (3D-CRT) for the thoracic esophageal cancer.Methods A total of 15 patients with thoracic esophageal cancer were enrolled.3D-CRT,5-field IMRT( IMRT5 ),7-field IMRT( IMRT7 ),9-field IMRT ( IMRT9 ),single arc ( Arc1 ) and double arc ( Arc2 ) RapidArc plans were generated for each patient.All plans were prescribed 40 Gy in 20 fractions and 19.6 Gy in 14 fractions to PTV at 95% isodose line.Results RapidArc and all IMRT treatment plans in dosimetric parameters of target volumes were obviously better compared to 3-dimentional conformal treatments( t =5.77,3.52,P < 0.05 ).The result of V95 of PTV for 3D-CRT,IMRT5,IMRT7,IMRT9,Arc1 and Arc2 plans was 91.55 ±2.90,96.66 ±1.05,96.87 ± 1.23,96.81 ± 1.16,94.98 ± 1.41 and 95.93 ± 1.32,respectively.The best conformation index in PTV was observed in the RapidArc plans ( t =3.76,10.01,P < 0.05 ),and the best homogeneity index in PTV was observed in the IMRT plans( t =3.93,3.37,P < 0.05 ).In terms of organ sparing,no statistical difference was observed between IMRT and RapidArc plans( P > 0.05 ),while 3D-CRT provided the lowest number of V1 cGy and V5 cGy for total lung.Compared with the IMRT treatment plans,the number of monitor units was lower in all 3D-CRT and RapidArc cases with differences of 75%.Conclusions All the IMRT and RapidArc plans could offer high quality treatment for patients.3D-CRT might show advantage in low-dose region to organs at risk.Compared with IMRT,no obvious advantage in PTV dosimetric parameters could be observed in RapidArc plans.